SABiosciences’ arrays will be validated for use on Fluidigm’s BioMark System and integrated fluidic circuits.
Fluidigm and SABiosciences are teaming up to create over 100 pathway-focused gene-expression panels validated for real-time PCR analysis on the Fluidigm BioMark™ System and its integrated fluidic circuits (IFCs). These kits are named the RT² Profiler™ PCR Arrays.
Each reagent kit includes prealiquoted reagents and primers needed for synthesizing first-strand cDNA ready for preamplification and pathway-focused analysis. PCR arrays contain enough reagent to run five 96.96 Dynamic Array chips, and customized panels are also available.
“SABiosciences’ solutions focusing on the analysis of pathways with real-time assay panel kits are an excellent fit to our products,” remarks Mike Lee, Fluidigm’s senior director of marketing. “The kits include 96 cataloged gene-expression assays, targeting genes in signal transduction, biological process, and disease-related pathways. The kits can provide a great solution for customers looking to lower start-up costs or that need prevalidated pathways for a new project.”
